Glycerol Phenylbutyrate Production Cost Reports

The report provides a detailed analysis essential for establishing a Glycerol Phenylbutyrate production plant. It encompasses all critical aspects necessary for Glycerol Phenylbutyrate production, including the cost of Glycerol Phenylbutyrate production, Glycerol Phenylbutyrate plant cost, Glycerol Phenylbutyrate production costs, and the overall Glycerol Phenylbutyrate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Glycerol Phenylbutyrate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Glycerol Phenylbutyrate is a highly specialised prescription medicine used for long-term metabolic management in both children and adults. It is used to help control high ammonia levels in people who have urea cycle disorders. It is widely used as an oral nitrogen-binding agent for the management of urea cycle disorders, which is a condition where the body is unable to eliminate waste nitrogen properly. It supports the process of lowering ammonia levels by helping convert waste into substances that can be safely removed from the body. It is also used in managing hepatic encephalopathy, which is a liver-related condition that can lead to a buildup of toxins affecting the brain.  Additionally, it is also used during monitoring programs where doctors track how well patients respond to ammonia-reducing medicines.

The market for Glycerol Phenylbutyrate is mainly driven by its demand as a drug in long-term treatment plans to control ammonia buildup in people with urea cycle disorders. Its application as a nitrogen-binding agent to facilitate safe excretion of excess nitrogen and control ammonia levels in the blood significantly promotes its demand in the medical sector. Its usage as a drug for long-term therapy and its suitability for patients who need reliable ammonia-reducing treatment further increase its demand in the healthcare and pharmaceutical industries.

In addition, growing awareness of rare metabolic diseases and improved diagnostic practices also contribute to its market demand. Industrial Glycerol Phenylbutyrate procurement is shaped by factors such as the cost and steady supply of raw materials, adherence to strict regulatory standards, production efficiency, and safe handling requirements. Meanwhile, advancements in formulation technology, supplier consistency, and global distribution capabilities significantly influence procurement decisions across the healthcare industry.

Raw Material for Glycerol Phenylbutyrate Production

According to the Glycerol Phenylbutyrate production plant project report, the major raw materials for Glycerol Phenylbutyrate production include 4-Phenylbutyryl Chloride and Glycerol.

Production Process of Glycerol Phenylbutyrate

The extensive Glycerol Phenylbutyrate production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Glycerol Phenylbutyrate begins with the reaction of 4-phenylbutyryl chloride and glycerol in the presence of an organic base such as imidazole or a 1-alkylimidazole. This reaction takes place in a C1–C5 chlorinated hydrocarbon solvent like dichloromethane or chloroform, under controlled low temperatures between -10 degree Celsius and 20 degree Celsius to ensure optimal reactivity and selectivity. The use of multiple equivalents of the acid chloride and base helps facilitate the esterification reaction to completion. Once the reaction is complete, the product is isolated and purified using chromatographic techniques, which results in the formation of high-purity Glycerol Phenylbutyrate as the final product.

Glycerol phenylbutyrate is an organic ester compound consisting of three molecules of phenylbutyrate linked to a glycerol backbone. It appears as a colourless to pale coloured liquid without a characteristic odour. It is generally supplied as an aqueous pharmaceutical solution rather than as a solid form. The molecular formula of the compound is C33H38O6 and its molar mass is approximately 530.65 g/mol. It has a high boiling point of around 621 degree Celsius, and its density value is 1.131 g/cm3. The compound is soluble in its formulation medium for therapeutic use, and it must be stored under controlled conditions. It can cause adverse effects, including gastrointestinal disturbances and risk of ammonia imbalance, as it is a medicinal agent. Handling and administration of the compound require strict precautions under professional guidance.